Atalaya Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Atalaya Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$58.9K	Hold	280,474	–	–	0.13%	23
2024 Q1	$61.7K	Hold	280,474	–	–	0.07%	34
2023 Q4	$53.3K	Hold	280,474	–	–	0.08%	34
2023 Q3	$72.9K	Hold	280,474	–	–	0.08%	41
2023 Q2	$112K	Buy	280,474 +201,755	+256%	+$61.6K	0.05%	53
2023 Q1	$24.4K	Hold	78,719	–	–	0.01%	122
2022 Q4	$19.7K	Hold	78,719	–	–	﹤0.01%	165
2022 Q3	$34K	Hold	78,719	–	–	﹤0.01%	217
2022 Q2	$41K	Hold	78,719	–	–	﹤0.01%	226
2022 Q1	$48K	Buy	+78,719	New	+$42.9K	0.01%	279

Other funds holding DRTSW

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Atalaya Capital Management's DRTSW Position: Q2 2024 in Review

Atalaya Capital Management held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2024 at 280,474 shares worth $58.9K. The position accounts for 0.13% of the portfolio, ranked #23.

Atalaya Capital Management first reported a position in DRTSW in Q1 2022 and has held it in 10 quarters since. The position peaked at $112K in Q2 2023. 26 funds tracked by Wall St. Rank hold DRTSW as of Q2 2024.

Atalaya Capital Management held 280,474 shares of Alpha Tau Medical Warrant worth $58.9K as of Q2 2024.
Atalaya Capital Management left its Alpha Tau Medical Warrant share count unchanged in Q2 2024.
Alpha Tau Medical Warrant made up 0.13% of Atalaya Capital Management's portfolio in Q2 2024, its #23 holding.
Atalaya Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 10 quarters since.
Atalaya Capital Management's Alpha Tau Medical Warrant position peaked at $112K in Q2 2023.
26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2024.

Based on Atalaya Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.